- Home
- CURI vs ORMP Comparison
CURI vs ORMP Comparison
Compare CURI & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURI | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.0M | 197.6M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | CURI | ORMP |
|---|---|---|
| Price | $2.91 | $4.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.83 | N/A |
| AVG Volume (30 Days) | ★ 739.8K | 152.9K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | ★ 10.36% | 6.51% |
| EPS Growth | 54.17 | ★ 412.50 |
| EPS | 0.12 | ★ 2.76 |
| Revenue | ★ $78,043,000.00 | $2,000,000.00 |
| Revenue This Year | $14.91 | N/A |
| Revenue Next Year | $12.91 | N/A |
| P/E Ratio | $24.25 | ★ $1.72 |
| Revenue Growth | 9.52 | ★ 49.25 |
| 52 Week Low | $2.30 | $2.09 |
| 52 Week High | $5.38 | $5.47 |
Technical Indicators
Market Signals| Indicator | CURI | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 52.99 | 47.15 |
| Support Level | $2.81 | $4.54 |
| Resistance Level | $2.97 | $5.01 |
| Average True Range (ATR) | 0.12 | 0.15 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 57.27 | 36.14 |
Price Performance
Historical ComparisonAbout CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.